Huntington’s Disease: a Blood Test “Speedometer”? (BBC News / Lancet Neurology)

Summary

Early research shows promise that a protein biomarker in the blood, called neurofilament light chain (NFL), which is released from damaged brain cells in Huntington’s Disease, may be the basis for a blood test able to predict whether people are at risk of developing Huntington’s disease and tracking how quickly the disease is progressing.

“We have been trying to identify blood biomarkers to help track the progression of Huntington’s Disease for well over a decade and this is the best candidate we have seen so far”. Dr Edward Wild (UCL).

Full Text Link

Reference

Mundasad, S. (2017). Huntington’s disease trial test is ‘major advance’.  London: BBC Health News, June 8th 2017.

This relates to:

Full Text Link

Reference

Byrne, LM. Rodrigues, FB. [and] Blennow, K. [et al] (2017). Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington’s disease: a retrospective cohort analysis. Lancet Neurology. June 7th 2017. [Epub ahead of print].

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in BBC News, Diagnosis, For Researchers (mostly), In the News, International, Quick Insights, UK, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s